AzTrials
AzTrials

Complex CareCHESSNCT07102433

Complexity in Health, Education, and Social Support for Children and Young People With Life-limiting Conditions.

An observational study of Complex Care and Medical Complexity, run by King's College London at 5 sites in United Kingdom.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Children and young people (CYP) with life-limiting conditions represent a growing population with complex care needs that span health, education, and social care systems. These children often have multiple diagnoses, rely on medical technologies, and experience prolonged trajectories of illness. Read more about this study

Who is it for?
Ages 5 years and older
Conditions the study is for
Complex Care, Medical Complexity, Pediatrics
What is being tested?
Children and young people with life-limiting conditions, their parents/carers, and professionals across healthcare, education, and social care sectors.
How many people
170 participants
Where
5 sitesUnited Kingdom
Study dates
1 Dec 2025to 30 Sep 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: The study population comprises: (1) children and young people aged 5-17 years with a life-limiting condition; (2) parents or carers of children aged 0-17, including bereaved parents (≥3 months post-bereavement); and (3) professionals from health, education, and social care with ≥6 months' experience supporting this population. Participants will be recruited from five NHS and hospice sites across England, selected for variation in geography, population served, and service model. Purposive sampling will be used to ensure diversity in age, diagnosis, ethnicity, socioeconomic status, and care setting. Professionals will be drawn from a range of disciplines across sectors using our professional networks.

Who may be able to join

  • Children (5-17 years) with any life-limiting condition defined using the UK Together for Short Lives widely adopted 4 categories of life-limiting/life-threatening conditions among children.
  • Parents/carers of children (0-17 years old) with a life-limiting conditions.
  • Bereaved parents of a child who had a life-limiting condition (at least 3 months since bereavement).
  • Healthcare professionals (medicine, nursing, allied health professionals), social care providers, education teaching and therapy staff with > 6 months experience of caring for children with life-limiting conditions.
  • Parents or carers of children with a life-limiting condition (0-17 years old).
  • Bereaved parents of a child who had a life-limiting condition (at least 3 months since bereavement).
  • Researchers working with or in the field of complexity in children with life-limiting conditions.
  • Professionals across child health, social care, and education with experience of working with children with life-limiting conditions for >6 months.

Who cannot join

  • Children unable to communicate via an interview, using 'draw and talk' or play methods, Talking MatsTM, or via their parents.
  • Children that speak languages not supported by NHS translation services.
  • Any child or young person for whom the PI believes participation in the study may induce undue psychological distress.
  • Parents/carers are unable to provide consent/assent to participate in interviews.
  • Parents/carers that speak languages not supported by NHS translation services.
  • Parents who are recently bereaved (<3 months).
Show all 13Show fewer
  • Any parent/carer for whom the PI believes participation in the study may induce undue psychological distress (e.g. parents of children who may be receiving end-of-life care).
  • Professionals with <6 months experience of caring for children with life-limiting conditions.
  • Stage 2 - Workshops
  • Professionals across child health, social care, and education with <6 months of experience working with children with life-limiting conditions.
  • Parents, carers, or professionals that are unable to provide consent or assent.
  • Children with life-limiting/life-threatening conditions will not be included in the workshops
  • Parents who are recently bereaved (<3 months) of a child who had a life-limiting condition.

Trial locations and contacts

5 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Lorna Fraser, PhD contact

richard.harding@kcl.ac.uk

5 sites in 1 country

United Kingdom5 sites, 5 recruiting
  • Birmingham Children's Hospital

    Birmingham, B46NH

    Mary Salama, +44 121 333 8163, mary.salama@nhs.net

    Recruiting
  • Chailey Clinical Services, Sussex Community NHS Foundation Trust

    Chailey, BN84JN

    Diane Sellers, +44 1825 722112, diane.sellers@nhs.net

    Recruiting
  • Shooting Star Children's Hospices

    Hampton, TW12 3RA

    Anna Karenia Anderson, +44 1483 230 960, annakarenia.anderson@nhs.net

    Recruiting
  • Guy's and St Thomas' NHS Foundation Trust

    London, SE1 9RT

    Lorna Fraser, PhD, +44 2078485518, lorna.fraser@kcl.ac.uk

    Recruiting
  • Royal Marsden Hospital

    London, SW36JJ

    Lucy Coombes, +44 20 8661 3625, lucy.coombes@rmh.nhs.uk

    Recruiting

Other trials in United Kingdom

About this study

Official title: CHESS - Complexity and Outcomes in Health, Education, and Social Support Among Children and Young People With Life-limiting Conditions: Establishing a Multisectoral Collaboration and Conceptual Framework to Advance Evidence and Practice.

Children and young people (CYP) with life-limiting conditions represent a growing population with complex care needs that span health, education, and social care systems. These children often have multiple diagnoses, rely on medical technologies, and experience prolonged trajectories of illness. Despite this, care remains fragmented, services are poorly integrated, and definitions of "complexity" are variable, inconsistent, and inadequately reflect the lived experience of families and the perspectives of professionals.

The CHESS (Complexity in Health, Education, and Social Support) study aims to develop a shared, evidence-informed understanding of "complexity" in the context of CYP with life-limiting conditions. The study will be delivered by a multi-disciplinary, multisectoral research team and is funded by a National Institute for Health and Care Research (NIHR) Programme Development Grant. This research will provide the foundational work to inform the design and implementation of a future NIHR Programme Grant focused on the development and testing of a child-centred, nationally applicable case mix classification system to support integrated multisector care and resource allocation.

Read more

This qualitative study involves two stages. Stage 1 consists of semi-structured interviews with (i) CYP aged 5-17 years with a life-limiting condition, (ii) parents/carers (including bereaved parents and parents of children aged under 5 years), and (iii) professionals across healthcare, social care, and education sectors. These interviews aim to elicit stakeholder understandings of "complexity," how it is experienced and enacted in care, and the implications for service access, coordination, and outcomes.

Stage 2 comprises a series of stakeholder workshops to review, refine, and synthesise findings from Stage 1 and a parallel realist review. Using consensus methods including the Nominal Group Technique, the workshops will co-develop a cross-sectoral conceptual definition of "complexity" and produce a logic model to guide integrated care delivery for this population.

The CHESS study seeks to address a critical evidence gap in how complexity is understood, measured, and supported across systems. By incorporating the voices of children, families, and professionals across sectors, this study will generate new conceptual clarity, build a foundation for improved outcomes, and contribute directly to the national agenda on equity, quality, and integration in paediatric palliative and complex care.

Read the detailed description
  1. Background and Rationale Children and young people living with life-limiting conditions (LLCs) represent a population with profoundly complex and multidimensional needs. These conditions, which include both life-limiting and life-threatening diagnoses, are characterised by an absence of curative options and, in many cases, uncertain illness trajectories. Advances in medical care mean that children often survive longer than previously expected, but with increasing medical, social, and educational complexity. Care for this group typically spans multiple sectors: highly specialised medical teams, allied health professionals, children's hospices, social services, and educational systems. Parents frequently report fragmented services, difficulties in navigating between health, education, and social care, and inequitable access to essential resources such as medical technologies, equipment, and tailored educational support. Despite being a relatively small population, these children account for disproportionately high resource utilisation, including frequent and prolonged hospital admissions, intensive care stays, and substantial reliance on community-based services. The absence of a shared definition of "complexity" across health, education, and social care settings poses a major barrier to effective care delivery. Services lack a consistent framework for recognising, measuring, and responding to complexity, resulting in inequitable distribution of resources and difficulties in evaluating outcomes. Research into children with neurodisability has attempted to capture aspects of complexity, but such tools are impractical in routine settings and insufficiently inclusive of the breadth of needs among children with LLCs. Previous initiatives have shown progress in developing outcome measures in paediatric palliative care and in mapping models of end-of-life care. However, no work has systematically brought together children, families, professionals, and policy stakeholders across sectors to build a conceptual model of complexity. In contrast, adult palliative care in the UK has successfully developed and implemented classification frameworks that inform both care and policy. A similar evidence base is urgently needed for children. The CHESS study (Complexity in Health, Education, and Social Support) addresses this evidence gap. By drawing on interviews with children, parents, and professionals, and by convening cross-sector workshops, this study will generate a consensus definition of complexity and a logic model of integrated multisector care. This framework will inform the development of a child-centred, nationally applicable classification system for future research and service planning.
  2. Study Purpose and Objectives The overarching purpose of CHESS is to build an evidence-based conceptual model of complexity in children with LLCs that is recognised across health, education, and social care sectors. This study is funded by the UK National Institute for Health and Care Research (NIHR) through a Programme Development Grant, and its outputs will underpin a future Programme Grant to design and test a case-mix classification for integrated care. Primary Objective To develop a cross-sector, evidence-based conceptual model of complexity for children with LLCs, derived from qualitative interviews and stakeholder workshops. Stage 1: Interviews To capture the perspectives of children, parents (including bereaved parents), and professionals on the meaning and operationalisation of "complexity." To understand children's experiences of their care needs, the supports they value, and barriers to meeting these needs. To identify parents' views on gaps in provision and how complexity influences the challenges they face. To explore professionals' definitions of complexity and their approaches to care planning. Stage 2: Workshops To build consensus on how complexity is defined and operationalised across sectors. To identify key components, processes, and outcomes essential for delivering integrated care. To develop a logic model of integrated care, with agreed indicators and outputs that reflect complexity. Secondary Objectives To establish a collaborative research partnership across multiple disciplines and sectors. To generate findings that support equitable resource allocation and guide future policy. To strengthen patient and public involvement (PPI) in conceptualising and shaping research on complexity.
  3. Study Design and Methodology This is a qualitative, multi-stage study consisting of two sequential components: Stage 1 - Semi-structured Interviews Participants: children (aged 5-17 years), parents/carers (including bereaved parents and parents of children aged under 5), and professionals (health, social care, education). Purpose: to capture diverse views on complexity, using purposive sampling to ensure variation in age, condition, ethnicity, socio-economic status, and professional background. Method: in-depth, semi-structured interviews, supported by age-appropriate tools (e.g., Talking Mats™, draw/play methods). Stage 2 - Stakeholder Workshops Three initial workshops (~30 participants each) involving parents, professionals, researchers, and carers. A final consensus workshop (~30 participants) using Nominal Group Technique to refine definitions and logic models. Data: transcripts and facilitated discussions analysed to develop a consensus definition and a framework for integrated care. The design is informed by a pragmatist research paradigm, acknowledging the experiential and contextual nature of complexity. Appreciative Inquiry principles will guide workshops, focusing on "what works" in integrated care. Study Duration: 9 months 31 days.
  4. Participants: Eligibility and Recruitment 4.1 Children and Young People Inclusion Aged 5-17 years. Diagnosed with a life-limiting condition (as defined by Together for Short Lives). Able to communicate verbally, through play/drawing, Talking Mats™, or via a parent proxy. Exclusion Unable to communicate using available methods. Non-English speakers where NHS translation services are unavailable. Considered by clinical staff at participating centres to be at risk of undue distress. Recruitment Through NHS trusts, hospices, and community organisations serving children with LLCs. Care teams identify eligible children and seek parental consent for contact. 4.2 Parents and Carers Inclusion Parents/carers of children aged 0-17 years with an LLC. Bereaved parents (>3 months since bereavement). Exclusion Recently bereaved (<3 months). Unable to provide informed consent. At risk of psychological harm if participating. 4.3 Professionals Inclusion Healthcare (medicine, nursing, allied health), social care, or education professionals with ≥6 months' experience caring for children with LLCs. Exclusion Professionals with <6 months' experience. 4.4 Workshop Participants Drawn from interview participants and wider networks. Must be able to provide informed consent. Children are not included in workshops. Sample Size Estimates Interviews: 10-20 children, ≥30 parents/carers, ≥30 professionals. Workshops: ~90 participants across three initial workshops and one consensus session.
  5. Study Procedures 5.1 Interviews Conducted face-to-face or via secure video (Microsoft Teams). Duration: children (30-60 min), parents (60-90 min), professionals (~60 min). Interviews will be audio-recorded, transcribed verbatim, pseudonymised. Children's interviews will include rapport-building, discussion of daily life, care needs, support experiences, and hopes for improvement. Parents will be asked about daily care, experiences with services, barriers, and views on complexity. Professionals will discuss definitions of complexity, service challenges, and approaches to integration. Participants will receive £20 vouchers and reimbursement for travel/childcare. 5.2 Workshops Conducted remotely via Microsoft Teams to maximise accessibility. Three initial workshops will generate broad definitions and frameworks. A final workshop will synthesise findings using Nominal Group Technique. Outputs: consensus definition of complexity and a preliminary logic model.
  6. Data Management and Analysis Plan All identifiable data (e.g., consent forms, audio/video files) will be stored separately from transcripts. Data will be held on secure, password-protected King's College London SharePoint servers. Audio files will be transcribed by a GDPR-compliant service; audio destroyed after transcription. Video recordings of Talking Mats™ sessions will be analysed then deleted. Interview data will be analysed using Framework Analysis, ensuring transparency, coding consistency, and traceability. Workshop data will be analysed using Nominal Group Technique and the CDC guide for developing logic models. Emergent findings will be triangulated across children, parents, and professionals.
  7. Statistical Considerations This is a qualitative study; no hypothesis testing or quantitative statistical modelling is planned. Sample sizes are based on principles of pragmatic saturation, ensuring adequate diversity and depth of data. Interviews: expected saturation with ~60-80 participants. Workshops: sufficient numbers to capture balance between parents and professionals, with consensus tested through structured group methods.
  8. Ethics, Safety, and Risk Management Ethical Review: The study requires NHS REC and HRA approval. Informed Consent/Assent Parents provide written consent for themselves and for children under 16. Children aged 5-15 provide assent; those aged 16-17 provide consent where capacity is confirmed. Bereaved parents must be at least 3 months post-bereavement. Managing Distress Researchers trained in qualitative methods for sensitive topics. Distress protocol includes pausing/stopping interviews, signposting to support, and notifying care teams if needed. No disclosure of prognosis or new medical information will occur during interviews. Adverse Events Although AEs and SAEs are unlikely in qualitative research, any unexpected events (e.g., acute distress) will be recorded and reported according to NIHR and sponsor policies. Safeguarding The study complies with NIHR and KCL safeguarding guidelines. Children may have a parent or trusted adult present during interviews.
  9. Oversight, Roles, and Responsibilities Sponsor: King's College London - responsible for study initiation, management, and monitoring. Funder: NIHR Programme Development Grant (NIHR207608). Chief Investigator: Prof. Richard Harding (Cicely Saunders Institute). Co-Investigators: Multidisciplinary team spanning paediatric medicine, social care, ethics, education, and patient/public representation. Steering Committee: Includes patient and public involvement (PPI) members and professionals, meeting monthly to guide recruitment, methodology, and interpretation. Auditing/Monitoring: Sponsor may audit per UK Policy Framework for Health and Social Care.
  10. Dissemination and Impact

Findings will inform the development of a cross-sector conceptual model of complexity, which will underpin a subsequent NIHR Programme Grant proposal. Dissemination plans include:

Peer-reviewed publications in palliative care, paediatrics, education, and social policy journals.

Presentations at international conferences.

A public launch of the consensus definition, involving parents and carers.

Sharing findings with NHS England, local authorities, and professional associations.

Lay summaries and online dissemination co-developed with PPI representatives.

Ultimately, the study aims to provide a nationally applicable, child-centred framework for understanding complexity in LLCs, enabling more equitable service design, evaluation, and resource allocation.

Being tested
Children and young people with life-limiting conditions, their parents/carers, and professionals across healthcare, education, and social care sectors.
Keywords
Medical complexity, Pediatric palliative care, Life-limiting conditions, Life-threatening conditions, Children and young people

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Children and young people with life-limiting conditions, their parents/carers, and professionals across healthcare, education, and social care sectors.Other

    Children and young people with life-limiting conditions, their parents/carers, and professionals across healthcare, education, and social care sectors.

Study groups in NCT07102433
Study groupRoleWhat they receive
Interview and Workshop ParticipantsInterview and workshop participants will be formed from the following inclusion criteria: Children and Young People (CYP): * Aged 5-17 years * Diagnosed with a life-limiting condition (as defined by Together for Short Lives) Parents/Carers: * Parent/carer of a child aged 0-17 years with a life-limiting condition * Bereaved parent, where bereavement occurred ≥3 months ago Professionals (Health, Social Care, Education): * Working with CYP with life-limiting conditions for at least 6 months * Includes medical, nursing, allied health, social care, and educational professionals Workshop Participants: * Any of the above stakeholder types * Must be able to provide informed consent or assent
Receives: Other: Children and young people with life-limiting conditions, their parents/carers, and professionals across healthcare, education, and social care sectors.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Study Objective

    Use findings from stakeholder interviews and workshops to develop a cross-sector evidence-based conceptual model of complexity to inform delivery and assessment of high quality and integrated care.

    Measured: Total Duration of study - August 2025 to July 2026.

  2. Interviews - Research Question

    What does 'complexity' mean to stakeholders in relation to children with life-limiting conditions, with respect to their health, social care, and educational needs and how they are understood, planned, and delivered?

    Measured: Total study duration - August 2025 to July 2026

  3. Workshops Research Questions

    1. How is 'complexity' defined and operationalised across health, social care, and education for children and young people with life-limiting conditions?
    2. What components and processes are important for the delivery of integrated complex care?
    3. What outputs and indicators signal 'complexity' and appropriate care delivery?
    4. Which processes and outcomes are meaningful to evaluate?

    Measured: Total study duration - August 2025 to July 2026

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2025
  2. Study start1 Dec 2025
  3. Primary completion30 Sep 2026 (estimated)
  4. Study completion30 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Other
Enrolment
170 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07102433
Sponsor's protocol ID
IRAS 356844
Other IDs
NIHR207608
Acronym
CHESS
Status last verified
Jul 2026
First submitted
28 Jul 2025
Last updated
5 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: This is a qualitative study involving in-depth interviews and stakeholder workshops with children, parents (including bereaved parents), and professionals. Due to the nature of the data collected-highly personal, context-specific, and potentially identifiable-even after de-identification, individual participant data (IPD) will not be shared publicly. This decision is guided by ethical considerations, the sensitivity of participant narratives, and the need to preserve confidentiality in accordance with informed consent agreements and data governance policies. Summarised findings will be shared through academic publications, public reports, and stakeholder events.

Publications

  • Rahimzadeh V, Bartlett G, Longo C, Crimi L, Macdonald ME, Jabado N, Ells C. Promoting an ethic of engagement in pediatric palliative care research. BMC Palliat Care. 2015 Oct 16;14:50. doi: 10.1186/s12904-015-0048-5.

    PubMed 26474573
  • Low, J. (2019). A pragmatic definition of the concept of theoretical saturation. Sociological Focus 52(2), 131-139.

  • Fields D, Fraser LK, Taylor J, Hackett J. What does 'good' palliative care look like for children and young people? A qualitative study of parents' experiences and perspectives. Palliat Med. 2023 Mar;37(3):355-371. doi: 10.1177/02692163231154300. Epub 2023 Feb 24.

    PubMed 36825577
  • Fisher V, Atkin K, Fraser LK. The health of mothers of children with a life-limiting condition: A qualitative interview study. Palliat Med. 2022 Oct;36(9):1418-1425. doi: 10.1177/02692163221122325. Epub 2022 Sep 14.

    PubMed 36113084
  • Namisango E, Bristowe K, Murtagh FE, Downing J, Powell RA, Abas M, Lohfeld L, Ali Z, Atieno M, Haufiku D, Guma S, Luyirika EB, Mwangi-Powell FN, Higginson IJ, Harding R. Towards person-centred quality care for children with life-limiting and life-threatening illness: Self-reported symptoms, concerns and priority outcomes from a multi-country qualitative study. Palliat Med. 2020 Mar;34(3):319-335. doi: 10.1177/0269216319900137. Epub 2020 Feb 21.

    PubMed 32081084
  • Coombes LH, Wiseman T, Lucas G, Sangha A, Murtagh FE. Health-related quality-of-life outcome measures in paediatric palliative care: A systematic review of psychometric properties and feasibility of use. Palliat Med. 2016 Dec;30(10):935-949. doi: 10.1177/0269216316649155. Epub 2016 May 31.

    PubMed 27247087
  • Coombes L, Harethardottir D, Braybrook D, Roach A, Scott H, Bristowe K, Ellis-Smith C, Downing J, Bluebond-Langner M, Fraser LK, Murtagh FEM, Harding R. Design and Administration of Patient-Centred Outcome Measures: The Perspectives of Children and Young People with Life-Limiting or Life-Threatening Conditions and Their Family Members. Patient. 2023 Sep;16(5):473-483. doi: 10.1007/s40271-023-00627-w. Epub 2023 May 23.

    PubMed 37221441
  • Scott HM, Coombes L, Braybrook D, Roach A, Harethardottir D, Bristowe K, Ellis-Smith C, Downing J, Murtagh FE, Farsides B, Fraser LK, Bluebond-Langner M, Harding R. Spiritual, religious, and existential concerns of children and young people with life-limiting and life-threatening conditions: A qualitative interview study. Palliat Med. 2023 Jun;37(6):856-865. doi: 10.1177/02692163231165101. Epub 2023 Mar 28.

    PubMed 36978266
  • Coombes L, Braybrook D, Roach A, Scott H, Harethardottir D, Bristowe K, Ellis-Smith C, Bluebond-Langner M, Fraser LK, Downing J, Farsides B, Murtagh FEM, Harding R; C-POS. Achieving child-centred care for children and young people with life-limiting and life-threatening conditions-a qualitative interview study. Eur J Pediatr. 2022 Oct;181(10):3739-3752. doi: 10.1007/s00431-022-04566-w. Epub 2022 Aug 12.

    PubMed 35953678
  • McLorie EV, Hackett J, Fraser LK. Understanding parents' experiences of care for children with medical complexity in England: a qualitative study. BMJ Paediatr Open. 2023 Aug;7(1):e002057. doi: 10.1136/bmjpo-2023-002057.

    PubMed 37550084
  • Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007 Dec;19(6):349-57. doi: 10.1093/intqhc/mzm042. Epub 2007 Sep 14.

    PubMed 17872937
  • Roach A, Braybrook D, Marshall S. Reflective insights from developing a palliative care children and young people's advisory group. Palliat Med. 2021 Mar;35(3):621-624. doi: 10.1177/0269216320976035. Epub 2021 Jan 12.

    PubMed 33435853
  • Coghlan, A.T., Preskill, H., and Tzavaras Catsambas, T. (2003). An overview of appreciative inquiry in evaluation. New Directions for Evaluation 2003(100), 5-22.

  • Cohen E, Bruce-Barrett C, Kingsnorth S, Keilty K, Cooper A, Daub S. Integrated complex care model: lessons learned from inter-organizational partnership. Healthc Q. 2011;14 Spec No 3:64-70. doi: 10.12927/hcq.0000.22580.

    PubMed 22008576
  • Kaushik, V., and Walsh, C.A. (2019). Pragmatism as a research paradigm and its implications for social work research. Social Sciences 8(9), 255.

Questions about this trial

What is this clinical trial studying?

An observational study of Complex Care and Medical Complexity, run by King's College London at 5 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Richard Harding, PhD (02078485518 ext. +44, richard.harding@kcl.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Study Objective (time frame: Total Duration of study - August 2025 to July 2026.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07102433, which also lists 34 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in